In order to inquire into the antitumor mechanism of the anticarcinogen AT-158, we used mice bearing with HepA22 in vivo, while U251 and SKOV-3 cell lines in vitro in this essay.

• 为了探讨DHA复合物（AT-158）的抗肿瘤效应及作用机制，本文以H22肝癌细胞的荷瘤小鼠为体内实验模型，以U251星形胶质瘤细胞、SKOV-3卵巢癌细胞为体外培养实验模型，研究了AT-158在体内和体外对各种癌细胞的抑制作用。